Announced Tue, 30 Sept · 16:43 IST

Pursuant to Regulation 30 read with para A of Schedule III of SEBI (LODR ) Regulations,2015 please find the attached summery of our 39th AGM Proceedings held on 30-9-2025. Kindly take ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Colinz Laboratories held its 39th AGM on 30th September 2025 via video conferencing (OAVM), starting at 2:30 PM and ending at 3:12 PM. Dr. Mani L.S., Director, chaired the meeting and confirmed quorum along with the presence of board members, KMPs, statutory and secretarial auditors. Four resolutions were tabled for members' approval, including adoption of audited financial statements for FY ended 31 March 2025, re-appointment of Dr. Mani L.S. as director (retiring by rotation), appointment of Mr. Swapnil Jayeshbhai Madiyar as Non-Executive Non-Independent Director, and appointment of Mr. K.N. Menon as Whole-Time Director & CEO with remuneration approval (special resolution). Remote e-voting was open from 27th September 9:00 AM to 29th September 5:00 PM, with the scrutinizer required to submit a report within 48 hours.

Likely market impact

Routine AGM disclosure with no surprise items — confirms board continuity and leadership composition. Investors await the e-voting results (scrutinizer's report) within 48 hours to see if any resolutions faced dissent, which could move the stock in this thinly-traded micro-cap.